Tixagevimab, CAS 2420564-02-7

Product Description: Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Jinhui Dong, et al. Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail. Nat Microbiol. 2021 Oct;6(10):1233-1244./[2]Jean-Sélim DRIOUICH, et al. Activity of Tixagevimab/Cilgavimab against the Omicron variant of SARS-CoV-2 in a hamster model.

CAS Number: 2420564-02-7

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Infection

Solubility: 10 mM in DMSO

Target: SARS-CoV

• Artikelnummer: MEXHY-P99556-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99556-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated